Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients

被引:44
作者
Shen, Yong [1 ,2 ]
Zhang, Suzhan [1 ,2 ]
Sun, Ren [1 ,2 ,3 ]
Wu, Tingting [1 ,2 ,3 ]
Qian, Jing [2 ,4 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Canc,China Natl Minist Educ,Key Lab Canc Pre, Hangzhou 310009, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Collaborat Innovat Ctr Diag & Treatment Infect Di, ZJU UCLA Joint Ctr Med Educ & Res, Hangzhou 310058, Zhejiang, Peoples R China
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA
[4] Zhejiang Univ, Sch Med, Res Ctr Infect & Immun, Hangzhou 310058, Zhejiang, Peoples R China
来源
EMERGING MICROBES & INFECTIONS | 2015年 / 4卷
基金
中国国家自然科学基金;
关键词
adaptive immunity; EBV; immune evasion; innate immunity; NPC; NASOPHARYNGEAL CARCINOMA-CELLS; REGULATORY T-CELLS; MEMBRANE-PROTEIN; NF-KAPPA-B; ANTIGEN-PROCESSING FUNCTION; BURKITTS-LYMPHOMA CELLS; CLASS-II EXPRESSION; COMPLEX CLASS-I; DENDRITIC CELLS; LATENT MEMBRANE-PROTEIN-1;
D O I
10.1038/emi.2015.20
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Epstein-Barr virus (EBV) has been used as a paradigm for studying host-virus interactions, not only because of its importance as a human oncogenic virus associated with several malignancies including nasopharyngeal carcinoma (NPC) but also owing to its sophisticated strategies to subvert the host antiviral responses. An understanding of the interplay between EBV and NPC is critical for the development of EBV-targeted immunotherapy. Here, we summarize the current knowledge regarding the host immune responses and EBV immune evasion mechanisms in the context of NPC.
引用
收藏
页数:9
相关论文
共 176 条
  • [21] Tumour inflammasome-derived IL-1ß recruits neutrophils and improves local recurrence-free survival in EBV-induced nasopharyngeal carcinoma
    Chen, Lih-Chyang
    Wang, Li-Jie
    Tsang, Nang-Ming
    Ojcius, David M.
    Chen, Chia-Chun
    OuYang, Chun-Nan
    Hsueh, Chuen
    Liang, Ying
    Chang, Kai-Ping
    Chen, Chiu-Chin
    Chang, Yu-Sun
    [J]. EMBO MOLECULAR MEDICINE, 2012, 4 (12) : 1276 - 1293
  • [22] Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivoi
    Chen, ML
    Pittet, MJ
    Gorelik, L
    Flavell, RA
    Weissleder, R
    von Boehmer, H
    Khazaie, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (02) : 419 - 424
  • [23] Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men
    Chien, YC
    Chen, JY
    Liu, MY
    Yang, HI
    Hsu, MM
    Chen, CJ
    Yang, CS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (26) : 1877 - 1882
  • [24] An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival
    Choy, Elizabeth Yee-Wai
    Siu, Kam-Leung
    Kok, Kin-Hang
    Lung, Raymond Wai-Ming
    Tsang, Chi Man
    To, Ka-Fai
    Kwong, Dora Lai-Wan
    Tsao, Sai Wah
    Jin, Dong-Yan
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (11) : 2551 - 2560
  • [25] Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes
    Comoli, P
    Pedrazzoli, P
    Maccario, R
    Basso, S
    Carminati, O
    Labirio, M
    Schiavo, R
    Secondino, S
    Frasson, C
    Perotti, C
    Moroni, M
    Locatelli, F
    Siena, S
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (35) : 8942 - 8949
  • [26] Comprehensive Profiling of Epstein-Barr Virus MicroRNAs in Nasopharyngeal Carcinoma
    Cosmopoulos, Katherine
    Pegtel, Michiel
    Hawkins, Jared
    Moffett, Howell
    Novina, Carl
    Middeldorp, Jaap
    Thorley-Lawson, David A.
    [J]. JOURNAL OF VIROLOGY, 2009, 83 (05) : 2357 - 2367
  • [27] Stage-Specific Inhibition of MHC Class I Presentation by the Epstein-Barr Virus BNLF2a Protein during Virus Lytic Cycle
    Croft, Nathan P.
    Shannon-Lowe, Claire
    Bell, Andrew I.
    Horst, Danielle
    Kremmer, Elisabeth
    Ressing, Maaike E.
    Wiertz, Emmanuel J. H. J.
    Middeldorp, Jaap M.
    Rowe, Martin
    Rickinson, Alan B.
    Hislop, Andrew D.
    [J]. PLOS PATHOGENS, 2009, 5 (06)
  • [28] Binding of the Epstein-Barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF-α gene expression in monocytic cells via NF-κB involving PKC, P13-K and tyrosine kinases
    D'Addario, M
    Ahmad, A
    Morgan, A
    Menezes, J
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2000, 298 (05) : 765 - 778
  • [29] Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling
    Dawson, CW
    Tramountanis, G
    Eliopoulos, AG
    Young, LS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (06) : 3694 - 3704
  • [30] Expression and analysis of the Epstein-Barr virus BARF1-encoded protein from a tetracycline-regulatable adenovirus system
    de Turenne-Tessier, M
    Jolicoeur, R
    Middeldorp, JM
    Ooka, T
    [J]. VIRUS RESEARCH, 2005, 109 (01) : 9 - 18